Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17508019rdf:typepubmed:Citationlld:pubmed
pubmed-article:17508019lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17508019lifeskim:mentionsumls-concept:C0007117lld:lifeskim
pubmed-article:17508019lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:17508019lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17508019lifeskim:mentionsumls-concept:C1416467lld:lifeskim
pubmed-article:17508019lifeskim:mentionsumls-concept:C1527180lld:lifeskim
pubmed-article:17508019pubmed:issue10lld:pubmed
pubmed-article:17508019pubmed:dateCreated2007-9-14lld:pubmed
pubmed-article:17508019pubmed:abstractTextBasal cell carcinoma (BCC), the most common human cancer, undergoes spontaneous regression in certain circumstances, which is potentially immune-mediated. To understand the immune response surrounding BCCs, we characterized the genomic, protein, and cellular microenvironment associated with BCC in comparison to normal skin. Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment. Our findings suggest a dynamic state within the immune microenvironment associated with BCC. The finding of phenotypic T regs, in conjunction with immature DCs and Th2 cytokines, suggests an attenuated state of immunity to human BCC. In contrast, abundant CD8+ T cells, an interferon signal, and IL-12/23 suggest partial host antitumor response. A better understanding of these opposing forces within the immune microenvironment may facilitate development of more potent immune-based treatment for BCC and other human carcinomas.lld:pubmed
pubmed-article:17508019pubmed:languageenglld:pubmed
pubmed-article:17508019pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:citationSubsetIMlld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17508019pubmed:statusMEDLINElld:pubmed
pubmed-article:17508019pubmed:monthOctlld:pubmed
pubmed-article:17508019pubmed:issn1523-1747lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:KruegerJames...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:CarucciJohn...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:Guttman-Yassk...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:CardinaleIrma...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:HaiderAsifa...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:DarabiKamruzKlld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:LowesMichelle...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:KhatcherianAr...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:NovitskayaInn...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:Fuentes-Ducul...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:KaporisHelen...lld:pubmed
pubmed-article:17508019pubmed:authorpubmed-author:Whynot-Ertelt...lld:pubmed
pubmed-article:17508019pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17508019pubmed:volume127lld:pubmed
pubmed-article:17508019pubmed:ownerNLMlld:pubmed
pubmed-article:17508019pubmed:authorsCompleteYlld:pubmed
pubmed-article:17508019pubmed:pagination2391-8lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:meshHeadingpubmed-meshheading:17508019...lld:pubmed
pubmed-article:17508019pubmed:year2007lld:pubmed
pubmed-article:17508019pubmed:articleTitleHuman basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment.lld:pubmed
pubmed-article:17508019pubmed:affiliationLaboratory for Investigative Dermatology, Rockefeller University, New York, New York, USA.lld:pubmed
pubmed-article:17508019pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17508019pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:50943entrezgene:pubmedpubmed-article:17508019lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17508019lld:entrezgene
lhgdn:association:49524lhgdn:found_inpubmed-article:17508019lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508019lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17508019lld:pubmed